These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31883461)

  • 21. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
    Favaloro EJ; Mohammed S
    Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired von Willebrand syndrome: diagnostic problems and therapeutic options.
    Eikenboom JC; Tjernberg P; Van Marion V; Heering KJ
    Am J Hematol; 2007 Jan; 82(1):55-8. PubMed ID: 16986130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis associated with the presence of thrombophilia markers and mild reduction in von Willebrand factor.
    Favaloro EJ; Bonar R; Survela L; McDonald D; Koutts J; Sioufi J; Marsden K
    Lab Hematol; 2007; 13(4):128-34. PubMed ID: 18192144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
    Abshire T; Cox-Gill J; Kempton CL; Leebeek FW; Carcao M; Kouides P; Donfield S; Berntorp E
    J Thromb Haemost; 2015 Sep; 13(9):1585-9. PubMed ID: 25930155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study.
    Vangenechten I; Smejkal P; Zapletal O; Michiels JJ; Berneman Z; Zavrelova J; Blatný J; Penka M; Gadisseur A
    Thromb Haemost; 2019 Apr; 119(4):594-605. PubMed ID: 30722078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An approach to outreach patients with von Willebrand disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
    Sherif N; Goubran H; Hassan A; Burnouf T; El-Ekiaby M
    Haemophilia; 2014 Mar; 20(2):238-43. PubMed ID: 24251732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of a Paediatric Bleeding Questionnaire as a screening tool for von Willebrand disease in apparently healthy children.
    Mittal N; Naridze R; James P; Shott S; Valentino LA
    Haemophilia; 2015 Nov; 21(6):806-11. PubMed ID: 25982122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prepubertal Genital Bleeding: Examination and Differential Diagnosis in Pediatric Female Patients.
    McCaskill A; Inabinet CF; Tomlin K; Burgis J
    J Emerg Med; 2018 Oct; 55(4):e97-e100. PubMed ID: 30170834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of thromboelastography for the diagnosis of von Willebrand disease.
    Regling K; Kakulavarapu S; Thomas R; Hollon W; Chitlur MB
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27714. PubMed ID: 30945453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic strategies for detection of the von Willebrand syndrome].
    Eller T; Mayer J; Bomhard M; Keller F
    Beitr Infusionsther; 1992; 30():268-71. PubMed ID: 1284714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. von Willebrand Disease: Diagnostic Strategies and Treatment Options.
    Ng CJ; Di Paola J
    Pediatr Clin North Am; 2018 Jun; 65(3):527-541. PubMed ID: 29803281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.
    Favaloro EJ
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):553-64. PubMed ID: 21885953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a Pediatric Bleeding Questionnaire in the Screening of Von Willebrand Disease in Young Females at Menarche in the Primary Care Setting.
    Duran J; Lasky JL; Rodgers C
    J Pediatr Health Care; 2016; 30(5):408-13. PubMed ID: 26614275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Prevalence of von Willebrand disease in women with abnormal uterine bleeding.
    Goodman-Gruen D; Hollenbach K
    J Womens Health Gend Based Med; 2001 Sep; 10(7):677-80. PubMed ID: 11571097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of the collagen binding activity (VWF:CB) in the range of tests for the diagnosis and classification of von Willebrand disease.
    Ferhat-Hamida MY; Boukerb H; Hariti G
    Ann Biol Clin (Paris); 2015; 73(4):461-8. PubMed ID: 26411913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease.
    Seaman CD; Ragni MV
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):434-438. PubMed ID: 28874064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.